Printed From:

Help in more ways than one

CHECK WHAT WORKS FOR YOU AND CLICK SUBMIT

FILL OUT THE FORM BELOW

See if you qualify for a Toujeo Savings Card.

and set up your COACH preferences.

Answer these questions to find out.

If you already use a Sanofi Rx Savings Card, please go to Have a Savings Card already? Need help?

Let’s set up your preferences for COACH support

You can:

  • Receive one-on-one phone calls with a Nurse Coach
  • Get overall diabetes management support via email and text message
  • Let your healthcare professional know how you’re doing with Toujeo COACH

Please provide the following information:

Let’s get started so we can send you more information.

Keep your eye out for facts about Toujeo and tips for living with diabetes.

See if you qualify to activate your Toujeo Savings Card. Answer these questions to find out.

If your card only has an RxBIN number and RxGRP number (and NO Savings Card ID number) you will need to register for a new card. Click here.

**Required fields

Please enter the 9-digit savings card ID

Now that you qualify for the savings card, please provide us with your contact information.

Keep an eye out for facts about Toujeo and tips for living with diabetes.

To get COACH support please start by providing us with your contact information.

To get facts about Toujeo and tips for living with diabetes, please provide your contact information.

**Required Fields

Let’s set up your preferences for COACH support

Let’s set up your Toujeo COACH preferences so you can:

You can:

  • Receive one-on-one phone calls with a Nurse Coach
  • Get overall diabetes management support via email and text message
  • Let your healthcare professional know how you’re doing with Toujeo COACH

Please provide the following information:

Select how you would like to get COACH support (check all that apply).**

Let your healthcare professional know how you’re doing with Toujeo COACH (optional).

Help us understand what information is right for you. Which, if any, of the following medications do you currently take?**

Confirm you’ve reviewed the Registration Authorization and click the “SUBMIT” button to complete.

Registration Authorization

By providing my personal information and registering, I authorize Sanofi US, its affiliates, and their contracted service providers (collectively “Sanofi”) to:

  • Provide me with additional information about diabetes, Sanofi products and health conditions, promotions, services, and to ask my opinion about such information and topics, including through market research and related surveys; 
  • If available and upon my request (either separately or through this registration), enroll me in a support program for which I may be eligible, which may include additional communications as described in the program;
  • Contact me for follow-up on any adverse event I may report regarding a Sanofi product;
  • Use my personal information, which may include personal health information, as described herein, and to contact me through periodic or recurring mail, email, phone calls, voice messages, internet-to-phone messages, SMS text messages, and interactive voice recordings using auto-dialers or prerecorded artificial or voice messages. This may include additional email or text messaging terms and conditions that may be provided to me in the future as part of a registration confirmation email or text message;
  • Combine my personal information with information about me from third parties to better match the communications or materials with my interests;
  • De-identify my personal information and use it in performing research, education, business analytics, marketing studies or for other commercial purposes; and
  • Share my personal information within the Sanofi parties above in order to de-identify it for the purposes described above and as needed to provide any services or communications.
  • I agree to allow Sanofi to use my personal information for the purposes described above.  In addition:
  • I confirm that I am the subscriber for the telephone numbers provided, I possess the mobile phone, and I am the authorized user for the email address; 
  • I agree to contact Sanofi if my phone, mail or email information changes or if I no longer possess the mobile phone; 
  • I understand that I can get help for text messages by texting HELP and I may opt-out of these communications by using one of the options set forth below or by sending STOP in response to the SMS/text.  Message and Data Rates May Apply; 
  • I understand that once my health information is provided to Sanofi, Federal privacy laws may not protect it from further disclosures;
  • I understand that Sanofi agrees to protect my health information by using and disclosing it only for the purposes allowed by me in this Registration Authorization or as otherwise allowed by law, and Sanofi will not sell or rent my information to unauthorized parties or mailing lists; 
  • I understand that I am not required to register or provide my information and it will not impact my ability to get health care, including any Sanofi medications prescribed by my physician; however, it will impact my ability to receive communications, or receive support through a program; 
  • I also understand that if I register, I may opt-out of receiving communications at any time by notifying Sanofi by telephone at 1-800-633-1610, by sending a letter to Sanofi US, 55 Corporate Drive, PO Box 5925, Mailstop 55A-220A, Bridgewater, NJ 08807, or by clicking Unsubscribe
  • I agree that I reviewed the Legal Disclaimer and Privacy Policy, which may be revised periodically, at http://www.privacypolicy.sanofi-aventis.us/ and
  • I understand that I may retain a copy of this Registration Authorization by taking a screenshot of this page.
Read full agreement in browser

Have Medicare Part D?

Most people get the lowest brand-name medication copay.

Find out facts
 

 

Renew your Sanofi Rx Savings Card

If you’ve received a communication to renew your Savings Card, please enter the following information below.

**Required fields

Date of Birth**

Replace your Sanofi Rx Savings Card

If you have lost or damaged a registered Sanofi Rx Savings Card, and wish to receive a new card, please enter your 10-digit phone number, your date of birth, and click “SUBMIT”.

**Required fields

Date of Birth**

If you need assistance with your Sanofi Rx Savings Card, call 866-390-5622 between 8AM and 8PM ET, Monday through Friday (excluding holidays).

If you have already used any Sanofi Rx Savings Card for Toujeo (or other Sanofi diabetes product), then good news!

You do not need to re-register or take any extra steps.

  • The $10 copay offer will automatically be honored at your pharmacy. Simply ask your pharmacist to process your next refill using your existing card.
  • Even if your healthcare provider gave you a new copay card for Toujeo, continue using your existing card. There is no need to spend time on registering again.
Receive another copy of your card
 

 
 

 

Prescription Lantus® is a long-acting insulin used to treat adults with type 2 diabetes and adults and pediatric patients (children 6 years and older) with type 1 diabetes for the control of high blood sugar.

Do not take Lantus® during episodes of low blood sugar or if you are allergic to insulin or any of the inactive ingredients in Lantus®.

Do not share needles, insulin pens, or syringes with others. Do NOT reuse needles.

Before starting Lantus®, tell your doctor about all your medical conditions, including if you have liver or kidney problems, if you are pregnant or planning to become pregnant or if you are breast-feeding or planning to breast-feed.

Heart failure can occur if you are taking insulin together with certain medicines called TZDs (thiazolidinediones), even if you have never had heart failure or other heart problems. If you already have heart failure, it may get worse while you take TZDs with Lantus®. Your treatment with TZDs and Lantus® may need to be changed or stopped by your doctor if you have new or worsening heart failure. Tell your doctor if you have any new or worsening symptoms of heart failure, including:

Tell your doctor about all the medications you take, including OTC medicines, vitamins, and supplements, including herbal supplements.

Lantus® should be taken once a day at the same time every day. Test your blood sugar levels while using insulin, such as Lantus®. Do not make any changes to your dose or type of insulin without talking to your healthcare provider. Any change of insulin should be made cautiously and only under medical supervision.

Do NOT dilute or mix Lantus® with any other insulin or solution. It will not work as intended and you may lose blood sugar control, which could be serious. Lantus® must only be used if the solution is clear and colorless with no particles visible. Always make sure you have the correct insulin before each injection.

While using Lantus®, do not drive or operate heavy machinery until you know how Lantus® affects you. You should not drink alcohol or use other medicines that contain alcohol.

The most common side effect of insulin, including Lantus®, is low blood sugar (hypoglycemia), which may be serious and life threatening. It may cause harm to your heart or brain. Symptoms of serious low blood sugar may include shaking, sweating, fast heartbeat, and blurred vision.

Lantus® may cause serious side effects that can lead to death, such as severe allergic reactions. Get medical help right away if you have:

Other possible side effects may include swelling, weight gain, low potassium levels, injection site reactions, including changes in fat tissue at the injection site, and allergic reactions.

Lantus® SoloSTAR® is a disposable prefilled insulin pen. Please talk to your healthcare provider about proper injection technique and follow instructions in the Instruction Leaflet that accompanies the pen.

Click here for Full Prescribing Information for Lantus®.

SOLIQUA 100/33 is an injectable prescription medicine that contains 2 diabetes medicines, insulin glargine and lixisenatide, that may improve blood sugar (glucose) control in adults with type 2 diabetes, when used with diet and exercise in people who are not controlled with long-acting (basal) insulin (less than 60 units daily) or lixisenatide.

What is the most important information I should know about SOLIQUA 100/33?
Do not share your SOLIQUA 100/33 pen with other people, even if the needle has been changed.

SOLIQUA 100/33 can cause serious side effects, including inflammation of the pancreas, which may be life-threatening.

Before using SOLIQUA 100/33, tell your doctor if you have had pancreatitis, stones in your gallbladder, or a history of alcoholism. These medical problems may make you more likely to get pancreatitis. Stop taking SOLIQUA 100/33 and call your healthcare provider right away if you have pain in your stomach area (abdomen) that is severe, and will not go away. The pain may be felt in the back area. The pain may happen with or without vomiting.

Who should not use SOLIQUA 100/33?
Do not use SOLIQUA 100/33 if you are having an episode of low blood sugar or if you are allergic to insulin glargine, lixisenatide, or any of the ingredients in SOLIQUA 100/33.

Tell your healthcare provider about all your medical conditions, including if you:

Tell your healthcare provider about all the medicines you take, including all prescription and over-the-counter medicines, vitamins, and herbal supplements. SOLIQUA 100/33 may affect the way some medicines work. Before using SOLIQUA 100/33, talk to your healthcare provider about low blood sugar and how to manage it.

How should I use SOLIQUA 100/33?

SOLIQUA 100/33 may cause serious side effects, including:

The most common side effects of SOLIQUA 100/33 may include low blood sugar (hypoglycemia), stuffy or runny nose and sore throat, upper respiratory tract infection, headache, allergic reactions, nausea, and diarrhea. Nausea and diarrhea usually happen more often when you start using SOLIQUA 100/33.

Click here for Full Prescribing Information for SOLQUA 100/33.

Prescription Apidra ® is for adults with type 2 diabetes or adults and children (4 years and older) with type 1 diabetes to improve blood sugar control. Apidra® given by subcutaneous injection is usually used with a longer-acting insulin. When used as a mealtime insulin, Apidra ® should be given within 15 minutes before or within 20 minutes after starting a meal.

Apidra® may be infused subcutaneously by external insulin infusion pumps.

Do not use Apidra® during a low blood sugar reaction (hypoglycemia) or if you are allergic to any of the ingredients in Apidra®.

Do not share needles, insulin pens or syringes with others. Do NOT reuse needles.

You must test your blood sugar levels while using insulin, such as Apidra®. Do not make any changes to your dose or type of insulin without talking to your healthcare provider. Any change of insulin should be made cautiously and only under medical supervision. Apidra® must only be used if the solution is clear and colorless with no particles visible.

Apidra®, when given by injection under the skin, should not be mixed with insulins other than NPH. Do not mix Apidra® with any insulin when used in the pump or for intravenous administration.

The most common side effect of insulin, including Apidra®, is low blood sugar (hypoglycemia), which may be serious. Some people may experience symptoms such as shaking, sweating, fast heartbeat, and blurred vision. Severe hypoglycemia may be serious and life threatening. It may cause harm to your heart or brain. Other possible side effects may include low blood potassium, injection site reactions, such as changes in fat tissue at the injection site, and allergic reactions, such as itching and rash. Less common, but potentially more serious or life-threatening, is generalized allergy to insulin, including anaphylactic reactions.

Tell your doctor about other medicines, especially ones commonly called TZDs (thiazolidinediones), and supplements you are taking because they can change the way insulin works. Before starting Apidra®, tell your doctor about all your medical conditions including if you have liver or kidney problems, are pregnant or planning to become pregnant, or are breast-feeding or planning to breast-feed. If you have heart failure or other heart problems, it may get worse while you take TZDs with Apidra®.

It is important to always follow the instructions provided with your Apidra® prescription for use with an external insulin infusion pump. These instructions may differ from the instructions that accompany your insulin infusion pump. Failure to follow the Apidra® specific instructions may lead to serious side effects.

You must change the infusion set (reservoir, tubing, and catheter), and the Apidra® in the pump reservoir at least every 48 hours. Do not mix Apidra® with any insulin when used in the pump and do not dilute Apidra®.

If the pump or infusion set does not work right or in case of handling errors, you may not get the right amount of insulin. This can cause low blood sugar (hypoglycemia), high blood sugar (hyperglycemia), high amounts of sugar and ketones in your blood (ketosis) or a build-up of acid in your blood because your body is breaking down fat instead of sugar (diabetic ketoacidosis). It is important to have another way to inject Apidra® in case the pump does not work.

Apidra® has not been studied in children with type 2 diabetes or in children younger than 4 years of age with type 1 diabetes. In a clinical study of children with type 1 diabetes, there was a higher rate of severe symptomatic hypoglycemia in the two treatment groups (Apidra® or insulin lispro) compared to adult trials with type 1 diabetes.

Apidra® SoloSTAR ® is a disposable prefilled insulin pen. Please talk to your healthcare provider about proper injection technique and follow instructions in the Instruction Leaflet that accompanies the pen.

Click here for Full Prescribing Information for Apidra®.